Neoadjuvant Erlotinib Treatment in Patients with Resectable Non-Small Cell Lung Carcinoma

被引：0
作者：
Van Gool, Matthijs [1 ]
Kiomp, Houke [1 ]
机构：
[1] NKI AVL, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
neoadjuvant; Surgery; EGFR-TKI;
D O I：
10.1016/j.jtho.2016.11.834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.05-049
引用
收藏
页码：S644 / S645
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant therapy for resectable non-small cell lung cancer
    Welcker, Katrin
    Jonigk, Danny
    Kropf-Sanchen, Cornelia
    Tufman, Amanda
    Draube, Andreas
    Stenzinger, Albrecht
    Zaatar, Mohamed
    Thomas, Michael
    PNEUMOLOGIE, 2025, 79 (01): : 16 - 24
  • [2] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [3] Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients
    Xiong, Liwen
    Lou, Yuqing
    Bai, Hao
    Li, Rong
    Xia, Jinjing
    Fang, Wentao
    Zhang, Jie
    Han-Zhang, Han
    Lizaso, Analyn
    Li, Bing
    Gu, Aiqin
    Han, Baohui
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
  • [4] CANOPY-N: Neoadjuvant Canakinumab and Pembrolizumab in Patients With Surgically Resectable Non-Small Cell Lung Cancer
    Lee, J.
    Tsuboi, M.
    Garrido, P.
    Kim, E. S.
    Dong, T.
    Blin, C.
    Rodrik-Outmezguine, V.
    Mookerjee, B.
    Passos, V.
    Mok, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S260 - S260
  • [5] Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
    Godoy, Luis A.
    Chen, Joy
    Ma, Weijie
    Lally, Jag
    Toomey, Kyra A.
    Rajappa, Prabhu
    Sheridan, Roya
    Mahajan, Shirish
    Stollenwerk, Nicholas
    Phan, Chinh T.
    Cheng, Danny
    Knebel, Robert J.
    Li, Tianhong
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [6] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    HELIYON, 2023, 9 (09)
  • [7] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [8] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [9] Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice
    Huang, Xiaojie
    Pang, Guanchao
    Mao, Zhirong
    Li, Baizhou
    Teng, Zhihua
    Yang, Yan
    Qiu, Zijian
    Chen, Xiuxiu
    Wang, Pingli
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05)
  • [10] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
12345